Clinical Trial

Da Qing Offspring Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This is an observational study tracking families and offspring of three cohorts from the 1986 Da Qing study: newly diagnosed diabetes, impaired glucose tolerance, and normoglycemia groups. Based on the original participants, the study will further include their spouses, first to third-generation offspring, and spouses of the offspring. General demographic information will be collected, and anthropometric measurements will be refined. A structured questionnaire will be used to gather disease history, family history of diabetes, and related information. Comprehensive diabetes-related laboratory screening and complication assessments will be conducted. A standardized biobank will be established, including blood and urine samples from the Da Qing Offspring Study, to support future research on epigenetics, metabolomics, and other mechanisms.
Trial Details
NCT Number NCT06958640
Lead Sponsor China-Japan Friendship Hospital
Collaborators: Daqing Oil Field Hospital
Conditions Diabetes Mellitus, Cardiovascular Diseases (CVD), Offspring, Adult, Impaired Glucose Tolerance (Prediabetes), Prevention, Cancer, Comorbidity, Inter- and Transgenerational Inheritance
Enrollment 5,000 participants
Start Date 2025-04-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-06